$AMPE Headlines 6 stocks to watch 2:56 p.m. Ju
Post# of 88930
Posted On: 01/26/2015 12:40:17 PM
$AMPE Headlines
6 stocks to watch 2:56 p.m. June 18, 2014 - The Trading Deck
Friday’s biggest gaining and declining stocks 3:26 p.m. July 13, 2012 - MarketWatch
Stocks to watch Friday: Lexmark, New York & Co. 5:47 a.m. July 13, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:50 p.m. June 11, 2012 - MarketWatch
Ampio: Optina has potential for diabetic treatment 11:46 a.m. June 11, 2012 - MarketWatch.com
Ampio shares add 27% after positive trial results 6:26 a.m. June 11, 2012 - Greg Morcroft
Tuesday’s biggest gaining and declining stocks 12:50 p.m. March 20, 2012 - Kate Gibson
Ampio rallies on eye-drug study 11:52 a.m. March 19, 2012 - Val Brickates Kennedy
Ampio tumbles on stock placement 2:50 p.m. Dec. 21, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 4:38 p.m. Dec. 19, 2011 - Greg Morcroft
Ampio Pharmaceuticals tumbles on drug concerns 2:57 p.m. Dec. 15, 2011 - Val Brickates Kennedy
Interesting AMPE Put And Call Options For March 20th 53 min ago - TheStreet.com
Ampio Pharmaceuticals (AMPE) in Focus: Stock Surges 14.1% - Tale of the Tape 9:39 a.m. Jan. 15, 2015 - Zacks.com
Ampio Pharma up after Vyrix presentation 3:45 p.m. Jan. 14, 2015 - Seeking Alpha
Ampio off premarket on expansion of data analysis in STRUT trial 9:05 a.m. Nov. 12, 2014 - Seeking Alpha
10-Q: AMPIO PHARMACEUTICALS, INC. 8:33 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Ampio (AMPE) Continue to Surge Higher? - Tale of the Tape 9:01 a.m. Oct. 20, 2014 - Zacks.com
Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog 3:40 p.m. Oct. 17, 2014 - Zacks.com
ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape 8:32 a.m. Oct. 17, 2014 - Zacks.com
Tetraphase (TTPH) Crumbles: Stock Tanks by 15% - Tale of the Tape 7:55 a.m. Oct. 17, 2014 - Zacks.com
Ohr Pharmaceutical's OHR-102 to Enter Phase III in 1H15 - Analyst Blog 6:00 p.m. Oct. 16, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4% - Tale of the Tape 8:32 a.m. Oct. 15, 2014 - Zacks.com
ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog 4:05 p.m. Oct. 14, 2014 - Zacks.com
Esperion Therapeutics Slumps: ESPR Falls 6.3% in Session - Tale of the Tape 7:48 a.m. Oct. 13, 2014 - Zacks.com
Genocea Up on Positive GEN-003 Data for Genital Herpes - Analyst Blog 1:57 p.m. Oct. 9, 2014 - Zacks.com
Xenon Pharma on deck for IPO 10:57 a.m. Oct. 7, 2014 - Seeking Alpha
Karyopharm Therapeutics, Inc. (KPTI) Surges: Stock Adds 10.5% - Tale of the Tape 8:11 a.m. Sept. 29, 2014 - Zacks.com
Another Mixed Stock Market Day but Indexes May Go Higher Friday 4:24 p.m. Sept. 11, 2014 - TheStreet.com
U.S. Stocks Stage Unimpressive Rebound as Apple Leads the Way 4:42 p.m. Sept. 10, 2014 - TheStreet.com
Simple Math Shows Ampio Knee Arthritis Drug is No Better Than Saline 11:04 a.m. Sept. 3, 2014 - TheStreet.com
Ampio Pharmaceuticals (AMPE): Today's Weak On High Volume Stock 9:05 a.m. Sept. 3, 2014 - TheStreet.com
Luoxis Establishes Initial European Distribution Network for RedoxSYS™ Diagnostic System 8:00 a.m. Jan. 22, 2015 - PR Newswire - PRF
Vyrix Pharmaceuticals to Present at Biotech Showcase™ 2015 7:57 a.m. Jan. 8, 2015 - PR Newswire - PRF
Luoxis to Present at Biotech Showcase 2015 8:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Ampio Pharmaceuticals to present at the Oppenheimer Annual Healthcare Conference on December 11th, 2014 8:00 a.m. Dec. 4, 2014 - PR Newswire - PRF
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (STRUT) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twenty of the Trial 8:00 a.m. Dec. 1, 2014 - PR Newswire - PRF
Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Ampio updates status of clinical trials and manufacturing facility 8:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Technical Report on Pharma Stocks - Auxilium Pharma, Perrigo, Endo Intl., Depomed, and Ampio Pharma 7:45 a.m. Oct. 24, 2014 - PR Newswire - PRF
Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (MI) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twelve of the Trial 3:02 p.m. Oct. 16, 2014 - PR Newswire - PRF
Ampio Pharmaceuticals Announces Webcast for Annual Shareholder Meeting 1:00 p.m. Sept. 15, 2014 - PR Newswire - PRF
Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp. 7:40 a.m. Sept. 15, 2014 - PR Newswire - PRF
Robbins Arroyo LLP is Investigating the Officers and Directors of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Shareholders 1:43 p.m. Aug. 28, 2014 - GlobeNewswire
Letter to the Ampio Shareholders in Regard to the STEP Study and Ampio's plans for the Ampion™ BLA 6:56 a.m. Aug. 25, 2014 - PR Newswire - PRF
Ampio reports that due to temperature deviations below product specifications during shipments to the Ampion™ STEP Study clinical sites, release of data will be delayed 6:56 a.m. Aug. 21, 2014 - PR Newswire - PRF
Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 6:56 a.m. Aug. 19, 2014 - PR Newswire - PRF
Ampio Announces Very Positive Results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Six of the Trial 7:00 a.m. Aug. 18, 2014 - PR Newswire - PRF
Luoxis Broadens Global Research Network for RedoxSYS™ oxidation-reduction potential (ORP) diagnostic system; Announces 17 Studies Currently Underway and Additional 30 Studies Set to Begin in 2014 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Ampio announces positive results on the open label portion of the Multiple injection Study of Ampion™ in patients with osteoarthritis of the knee. 7:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
Ophthalmic Drugs Market Forecast 2014-2024: Prospects for Leading Companies 10:55 a.m. Aug. 4, 2014 - PR Newswire - PRF
6 stocks to watch 2:56 p.m. June 18, 2014 - The Trading Deck
Friday’s biggest gaining and declining stocks 3:26 p.m. July 13, 2012 - MarketWatch
Stocks to watch Friday: Lexmark, New York & Co. 5:47 a.m. July 13, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:50 p.m. June 11, 2012 - MarketWatch
Ampio: Optina has potential for diabetic treatment 11:46 a.m. June 11, 2012 - MarketWatch.com
Ampio shares add 27% after positive trial results 6:26 a.m. June 11, 2012 - Greg Morcroft
Tuesday’s biggest gaining and declining stocks 12:50 p.m. March 20, 2012 - Kate Gibson
Ampio rallies on eye-drug study 11:52 a.m. March 19, 2012 - Val Brickates Kennedy
Ampio tumbles on stock placement 2:50 p.m. Dec. 21, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 4:38 p.m. Dec. 19, 2011 - Greg Morcroft
Ampio Pharmaceuticals tumbles on drug concerns 2:57 p.m. Dec. 15, 2011 - Val Brickates Kennedy
Interesting AMPE Put And Call Options For March 20th 53 min ago - TheStreet.com
Ampio Pharmaceuticals (AMPE) in Focus: Stock Surges 14.1% - Tale of the Tape 9:39 a.m. Jan. 15, 2015 - Zacks.com
Ampio Pharma up after Vyrix presentation 3:45 p.m. Jan. 14, 2015 - Seeking Alpha
Ampio off premarket on expansion of data analysis in STRUT trial 9:05 a.m. Nov. 12, 2014 - Seeking Alpha
10-Q: AMPIO PHARMACEUTICALS, INC. 8:33 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Ampio (AMPE) Continue to Surge Higher? - Tale of the Tape 9:01 a.m. Oct. 20, 2014 - Zacks.com
Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog 3:40 p.m. Oct. 17, 2014 - Zacks.com
ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape 8:32 a.m. Oct. 17, 2014 - Zacks.com
Tetraphase (TTPH) Crumbles: Stock Tanks by 15% - Tale of the Tape 7:55 a.m. Oct. 17, 2014 - Zacks.com
Ohr Pharmaceutical's OHR-102 to Enter Phase III in 1H15 - Analyst Blog 6:00 p.m. Oct. 16, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4% - Tale of the Tape 8:32 a.m. Oct. 15, 2014 - Zacks.com
ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog 4:05 p.m. Oct. 14, 2014 - Zacks.com
Esperion Therapeutics Slumps: ESPR Falls 6.3% in Session - Tale of the Tape 7:48 a.m. Oct. 13, 2014 - Zacks.com
Genocea Up on Positive GEN-003 Data for Genital Herpes - Analyst Blog 1:57 p.m. Oct. 9, 2014 - Zacks.com
Xenon Pharma on deck for IPO 10:57 a.m. Oct. 7, 2014 - Seeking Alpha
Karyopharm Therapeutics, Inc. (KPTI) Surges: Stock Adds 10.5% - Tale of the Tape 8:11 a.m. Sept. 29, 2014 - Zacks.com
Another Mixed Stock Market Day but Indexes May Go Higher Friday 4:24 p.m. Sept. 11, 2014 - TheStreet.com
U.S. Stocks Stage Unimpressive Rebound as Apple Leads the Way 4:42 p.m. Sept. 10, 2014 - TheStreet.com
Simple Math Shows Ampio Knee Arthritis Drug is No Better Than Saline 11:04 a.m. Sept. 3, 2014 - TheStreet.com
Ampio Pharmaceuticals (AMPE): Today's Weak On High Volume Stock 9:05 a.m. Sept. 3, 2014 - TheStreet.com
Luoxis Establishes Initial European Distribution Network for RedoxSYS™ Diagnostic System 8:00 a.m. Jan. 22, 2015 - PR Newswire - PRF
Vyrix Pharmaceuticals to Present at Biotech Showcase™ 2015 7:57 a.m. Jan. 8, 2015 - PR Newswire - PRF
Luoxis to Present at Biotech Showcase 2015 8:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Ampio Pharmaceuticals to present at the Oppenheimer Annual Healthcare Conference on December 11th, 2014 8:00 a.m. Dec. 4, 2014 - PR Newswire - PRF
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (STRUT) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twenty of the Trial 8:00 a.m. Dec. 1, 2014 - PR Newswire - PRF
Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Ampio updates status of clinical trials and manufacturing facility 8:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Technical Report on Pharma Stocks - Auxilium Pharma, Perrigo, Endo Intl., Depomed, and Ampio Pharma 7:45 a.m. Oct. 24, 2014 - PR Newswire - PRF
Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (MI) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twelve of the Trial 3:02 p.m. Oct. 16, 2014 - PR Newswire - PRF
Ampio Pharmaceuticals Announces Webcast for Annual Shareholder Meeting 1:00 p.m. Sept. 15, 2014 - PR Newswire - PRF
Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp. 7:40 a.m. Sept. 15, 2014 - PR Newswire - PRF
Robbins Arroyo LLP is Investigating the Officers and Directors of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Shareholders 1:43 p.m. Aug. 28, 2014 - GlobeNewswire
Letter to the Ampio Shareholders in Regard to the STEP Study and Ampio's plans for the Ampion™ BLA 6:56 a.m. Aug. 25, 2014 - PR Newswire - PRF
Ampio reports that due to temperature deviations below product specifications during shipments to the Ampion™ STEP Study clinical sites, release of data will be delayed 6:56 a.m. Aug. 21, 2014 - PR Newswire - PRF
Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 6:56 a.m. Aug. 19, 2014 - PR Newswire - PRF
Ampio Announces Very Positive Results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Six of the Trial 7:00 a.m. Aug. 18, 2014 - PR Newswire - PRF
Luoxis Broadens Global Research Network for RedoxSYS™ oxidation-reduction potential (ORP) diagnostic system; Announces 17 Studies Currently Underway and Additional 30 Studies Set to Begin in 2014 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Ampio announces positive results on the open label portion of the Multiple injection Study of Ampion™ in patients with osteoarthritis of the knee. 7:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
Ophthalmic Drugs Market Forecast 2014-2024: Prospects for Leading Companies 10:55 a.m. Aug. 4, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼